In This Case, Being Lucky Takes a Whole Lot of Work | GenomeWeb

Northwestern University's Richard Silverman and his work leading to the discovery and marketing of Pfizer's blockbuster, Lyrica, are profiled in this Chicago Tribune article. According to Silverman, who took one-fourth of the $700 million in royalties Northwestern made selling a portion of its rights to New York-based Royalty Pharma, finding a billion-dollar drug takes as much scientific curiosity as luck.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.